Latest Earnings Analysis

• APEI Q4 2022: Rasmussen Enrollment Drops 12% as APUS and Hondros Offset Margin Pressure
  March 14, 2023 · APEI
• AMLX Q4 2022: Relivrio Patient Base Doubles as U.S. Launch Drives Early Uptake
  March 13, 2023 · AMLX
• BigBear.ai (BBAI) Q4 2022: Analytics Segment Grows 39%, Accelerating Margin Shift
  March 13, 2023 · BBAI
• American Vanguard (AVD) Q4 2022: Green Solutions Revenue Jumps 32% as Core Margins Hold Amid Volatility
  March 13, 2023 · AVD
• AirSculpt (AIRS) Q4 2022: De Novo Centers Fuel 16% Case Volume Surge, Margin Focus Intensifies
  March 10, 2023 · AIRS
• Buckle (BKE) Q4 2022: Inventory Up 22% as Denim and Private Label Strategy Anchor Margin Defense
  March 10, 2023 · BKE
• AKA Brands (AKA) Q4 2022: Inventory Down $17M as Omnichannel Tests Offset 18% Sales Drop
  March 09, 2023 · AKA
• Airgain (AIRG) Q4 2022: Enterprise Sales Surge 41% as IoT and EV Charging Expand Revenue Base
  March 09, 2023 · AIRG
• Akebia (AKBA) Q4 2022: Oxbryta Revenue Jumps 25% as EU Vatadustat Decision Nears
  March 09, 2023 · AKBA
• Aldeyra (ALDX) Q4 2022: $174M Cash Extends Runway Through 2024 as Dual NDA Reviews Reshape Pipeline Trajectory
  March 09, 2023 · ALDX
• Alta Equipment Group (ALTG) Q4 2022: Product Support Revenue Climbs 70% Since 2020, Showcasing Scale Leverage
  March 09, 2023 · ALTG
• Alto Ingredients (ALTO) Q4 2022: $125M Project Pipeline Targets 2x EBITDA by 2026
  March 09, 2023 · ALTO
• Archer Aviation (ACHR) Q4 2022: Stellantis Partnership Unlocks $150M Capital, Accelerates eVTOL Ramp
  March 09, 2023 · ACHR
• AMTX Q4 2022: $67.9M Cost Surge Flips Margins, Biogas and India Units Poised for 2023 Upside
  March 09, 2023 · AMTX
• AudioEye (AEYE) Q4 2022: Operating Expenses Drop 19% Amid Strategic Contract Resets
  March 09, 2023 · AEYE
• ANI Pharmaceuticals (ANIP) Q4 2022: Rare Disease Revenue Set to Double, Generics Margin Expands
  March 09, 2023 · ANIP
• AOMR Q4 2022: Warehouse Debt Cut by 60%, Resetting Risk Profile Amid Non-QM Headwinds
  March 09, 2023 · AOMR
• American Outdoor Brands (AOUT) Q3 2023: Inventory Down $15M, DTC Grows 37% Amid Retail Destocking
  March 09, 2023 · AOUT
• Arhaus (ARHS) Q4 2022: $40M Backlog Pull-Forward Amplifies Margin Surge, Sets Up Transitional 2023
  March 09, 2023 · ARHS
• Mission Produce (AVO) Q1 2023: Avocado Volume Up 14% as Pricing Drops 27%
  March 09, 2023 · AVO
• AvePoint (AVPT) Q4 2022: SaaS Mix Climbs to 52%, Channel Acceleration Shapes Margin Outlook
  March 09, 2023 · AVPT
• AWRE Q4 2022: Recurring Revenue Hits 61% of Total, Accelerating Platform Transition
  March 09, 2023 · AWRE
• BBCP Q1 2023: Ecopan Surges 32% as Commercial Mix Offsets Residential Slowdown
  March 09, 2023 · BBCP
• Build-A-Bear Workshop (BBW) Q4 2022: Pre-Tax Income Jumps 30% as Brand Expansion Drives Record Profitability
  March 09, 2023 · BBW
• BGSF (BGSF) Q4 2022: Property Management Grows 31%, Shifting Portfolio to High-Margin Consulting
  March 09, 2023 · BGSF
• Allbirds (BIRD) Q4 2022: International Distributor Pivot Could Unlock $45M+ in Cost Savings
  March 09, 2023 · BIRD
• BJ’s Wholesale Club (BJ) Q4 2022: Membership Renewal Hits 90% as Fresh, Digital, and Club Expansion Drive Next-Stage Growth
  March 09, 2023 · BJ
• Bakkt (BKKT) Q4 2022: Headcount Cut 40% to Drive $36M Cost Savings as B2B Crypto Focus Deepens
  March 09, 2023 · BKKT
• BNED Q3 2023: First Day Complete Revenue Surges 76% as Equitable Access Model Accelerates
  March 09, 2023 · BNED
• Asana (ASAN) Q4 2023: $100K+ Customer Revenue Jumps 80% as Enterprise Focus Drives Margin Gains
  March 08, 2023 · ASAN
• Aquestive Therapeutics (AQST) Q4 2022: Non-Dilutive Capital Surges Past $45M, Pivotal Epinephrine Study on Deck
  March 08, 2023 · AQST
• ABM (ABM) Q1 2023: $450M ATS Backlog Anchors Second-Half Growth Despite Margin Compression
  March 08, 2023 · ABM
• BBVA Argentina (BBAR) Q4 2022: Digital Sales Climb to 83.9% of Units, Margin Upside Persists Amid Volatile Macro
  March 07, 2023 · BBAR
• Autolus Therapeutics (AUTL) Q4 2022: $220M Blackstone Funding Secured as OB-Cell Durability Signals Competitive Edge
  March 07, 2023 · AUTL
• Arlo (ARLO) Q4 2022: Services Revenue Surges 53%, Reshaping Margin Profile
  March 07, 2023 · ARLO
• AFCG Q4 2022: CECL Reserve Jumps 176% as Lending Shifts Toward 50% Non-Cannabis Mix
  March 07, 2023 · AFCG
• Biodesix (BDSX) Q4 2022: Core Lung Diagnostics Revenue Jumps 57% as Test Adoption Accelerates
  March 06, 2023 · BDSX
• Anika (ANIK) Q4 2022: Joint Preservation Revenue Climbs 8% as Product Launches Drive Inflection
  March 06, 2023 · ANIK
• AirSculpt (ASLE) Q4 2022: Feedstock Wins Double to $107M, Positioning for H2 Upside
  March 06, 2023 · ASLE
• AeroVironment (AVAV) Q3 2023: Backlog Surges 83% as Ukraine Demand Reshapes Growth Trajectory
  March 06, 2023 · AVAV
• Acme United (ACU) Q4 2022: First Aid Revenues Hit 55% of Total, Cost Actions Target $5M in Savings
  March 02, 2023 · ACU
• Best Buy (BBY) Q4 2023: Digital Sales Hold at 33% as Store Closures, Membership Revamp Signal Model Reset
  March 02, 2023 · BBY
• Arbutus Biopharma (ABUS) Q4 2022: Cash Runway Extended to Q4 2024 as Four Clinical Programs Advance
  March 02, 2023 · ABUS
• ARGX Q4 2022: VivGuard Reaches 3,000 Patients, Fueling Multinational Expansion and Pipeline Leverage
  March 02, 2023 · ARGX
• Alvotech (ALVO) Q4 2022: Revenue Doubles as U.S. Humira Biosimilar Launch Nears
  March 02, 2023 · ALVO
• C3.ai (AI) Q3 2023: 290+ Pilot Pipeline Signals Consumption Model Traction
  March 02, 2023 · AI
• Acres Commercial Realty (ACR) Q4 2022: CECL Reserve Rises to 0.91% as Loan Portfolio Holds at $2.1B
  March 02, 2023 · ACR
• Bilibili (BILI) Q4 2022: DAUs Jump 29% as Margin Focus Reshapes Growth Model
  March 02, 2023 · BILI
• Broadcom (AVGO) Q1 2023: AI Networking Revenue Set to Quadruple to $800M, Signaling Next-Gen Data Center Shift
  March 02, 2023 · AVGO
• Astronics (ATRO) Q4 2022: Backlog Hits $571M as Wide-Body Recovery Fuels Demand Visibility
  March 02, 2023 · ATRO